Delivery Order SPE2DP20D0002-SPE2DP21F3208
Award Date 4/6/21
Potential Completion Date 4/27/21
Potential Value $565K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $1,357,470 firm fixed price delivery order to supply adenovirus type 4. As a prime contractor on the agency's prime vendor indefinite-delivery/indefinite-quantity medical/surgical supply contract, Teva will deliver the requested products to a location in Parsippany, New Jersey between September 21st and 29th, 2020. No subcontractors or set aside designations were indicated. This delivery order supports...
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $564,707.52 firm fixed price delivery order to supply adenovirus type 4. The place of performance is Teva's facility in Parsippany, New Jersey. The contract period runs from April 6, 2021 through April 27, 2021. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals, medical supplies, and equipment. This delivery order allows the agency to obtain...
- The Defense Logistics Agency Troop Support Medical awarded a $705,884 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc. for adenovirus type 4. The place of performance is Teva's facility in Parsippany, New Jersey. The delivery order has a period of performance from February 11, 2021 through February 23, 2021. Teva will deliver the requested adenovirus type 4 to support the Defense Logistics Agency's medical supply chain programs. No subcontractors or set aside designations were...
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $610,787.52 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2023 through April 25, 2023. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. No subcontractors were identified.</p>
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $1.22 million firm fixed price delivery order to supply adenovirus type 4. The prime contractor will deliver the requested pharmaceutical to the agency's location in Parsippany, New Jersey by September 29, 2020, fulfilling requirements under an existing indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set aside designations were indicated. The Defense Logistics Agency...
- The Defense Logistics Agency Troop Support Medical awarded a $305,393.76 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc. of Parsippany, New Jersey. Under this contract, Teva will provide adenovirus type 4 to the agency. The contract has a period of performance starting on August 22, 2023 through August 29, 2023. As the Defense Logistics Agency supports the medical needs of the Department of Defense, this delivery order was likely placed to supply necessary pharmaceuticals for...
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $610,787.52 firm fixed price delivery order to supply adenovirus type 4 under contract number 8510134412. The prime contractor Teva Pharmaceuticals will deliver the requested pharmaceutical products from its facility located in Parsippany, New Jersey by September 19, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated. This...
- The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals Usa, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4. The contract has a period of performance starting on May 17, 2023 through May 23, 2023 and will be performed in Parsippany, New Jersey. Teva Pharmaceuticals Usa, Inc. is the prime contractor for this contract to supply the Defense Logistics Agency Troop Support Medical with adenovirus type 4, a virus that causes...
- The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $587,295.72 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2022 through April 26, 2022. The place of performance for this contract is Parsippany, New Jersey. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply adenovirus type 4 to the Defense Logistics Agency Troop Support Medical. No applicable subcontractors were identified.
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $282,353.76 firm fixed price delivery order contract to provide adenovirus type 4. The prime contractor, Teva Pharmaceuticals USA, Inc., will perform the work in Parsippany, New Jersey from December 7, 2021 through December 14, 2021.</p>
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP21F3208Delivery Order
The Defense Logistics Agency Troop Support Medical awarded a $564,707 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc. for adenovirus type 4. As a prime contractor on the agency's indefinite-delivery/indefinite-quantity pharmaceutical contract vehicle, Teva will deliver the requested viral product to a facility in Parsippany, New Jersey, with performance required between April 6th and 27th of this year. No set aside designation or subcontractor information was provided. This award supports DLA's medical supply chain responsibilities for the Department of Defense.
Generated 12/25/23, 12:21 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $564.7k | 4/6/21 |